CINECA IRIS Institutional Research Information System

FAVA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.825
EU - Europa 3.034
AS - Asia 1.344
SA - Sud America 116
AF - Africa 46
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 29
Totale 9.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.758
IT - Italia 1.121
CN - Cina 568
IE - Irlanda 360
SG - Singapore 294
DE - Germania 274
FR - Francia 238
SE - Svezia 194
FI - Finlandia 142
GB - Regno Unito 112
PL - Polonia 98
AT - Austria 90
IN - India 90
JP - Giappone 87
KR - Corea 86
ES - Italia 63
UA - Ucraina 63
VN - Vietnam 55
BR - Brasile 47
CA - Canada 46
NL - Olanda 46
TR - Turchia 43
AU - Australia 40
AR - Argentina 29
ID - Indonesia 29
EU - Europa 28
RU - Federazione Russa 27
BE - Belgio 25
CH - Svizzera 25
NO - Norvegia 24
HK - Hong Kong 23
RO - Romania 22
GR - Grecia 21
SN - Senegal 20
CL - Cile 17
MX - Messico 15
PE - Perù 15
DK - Danimarca 14
PT - Portogallo 13
CZ - Repubblica Ceca 10
TW - Taiwan 10
HU - Ungheria 8
SI - Slovenia 8
HR - Croazia 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
AM - Armenia 6
CO - Colombia 6
NG - Nigeria 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
IR - Iran 5
LV - Lettonia 5
AL - Albania 4
EG - Egitto 4
KW - Kuwait 4
LK - Sri Lanka 4
RS - Serbia 4
TH - Thailandia 4
TN - Tunisia 4
BG - Bulgaria 3
LB - Libano 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PA - Panama 3
QA - Qatar 3
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
IL - Israele 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
MY - Malesia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.437
Salva come PNG Salva come JPEG
Città #
Chandler 810
Dublin 359
Beijing 274
Fairfield 231
Singapore 230
Ashburn 224
Torino 165
Houston 146
Wilmington 145
Woodbridge 143
Ann Arbor 115
Redwood City 113
Princeton 112
Medford 111
Villeurbanne 107
Columbus 106
Nyköping 101
Seattle 101
Santa Clara 89
Jacksonville 87
Vienna 85
Cambridge 81
Warsaw 72
Dearborn 70
Pisa 70
Milan 57
New York 51
Rome 48
Turin 47
Guangzhou 38
Boston 34
Tokyo 32
Jakarta 26
Washington 26
Dong Ket 24
Hebei 24
Pune 22
Nanjing 21
Hangzhou 20
Brussels 19
Fremont 18
Los Angeles 18
Bologna 17
Shanghai 17
Florence 16
Philadelphia 16
Hefei 15
Munich 15
Ottawa 15
Chengdu 14
Leiden 14
Santiago 14
Helsinki 13
Istanbul 13
Kunming 13
Norwalk 12
Paris 12
Rochester 12
Silver Spring 11
São Paulo 11
Berlin 10
Buenos Aires 10
Duncan 10
Falls Church 10
Lima 10
Padova 10
Pavia 10
San Diego 10
Sydney 10
Amsterdam 9
Jinan 9
London 9
Madrid 9
Radomsko 9
Seoul 9
Zhengzhou 9
Baotou 8
Brescia 8
Genova 8
Saluzzo 8
Taipei 8
Toronto 8
Trondheim 8
Wuhan 8
Zurich 8
Hamburg 7
Mountain View 7
Pontevedra 7
Tianjin 7
Upper Marlboro 7
Verona 7
Abuja 6
Ankara 6
Barcelona 6
Bergamo 6
Central 6
Charlestown 6
Heraklion 6
Nürnberg 6
Phoenix 6
Totale 5.243
Salva come PNG Salva come JPEG
Nome #
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 450
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 364
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab 330
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 316
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 316
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 304
Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: An unusual clinical presentation 294
Metastasi cutanee da melanoma: l’esperienza della I Clinica Dermatologica di Torino 281
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 257
Atopic dermatitis in a phenylketonuric untreated patient 257
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients 232
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 213
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 207
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects. 207
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model 207
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 185
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 153
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 136
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 135
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 129
Fotoferesi: applicazioni terapeutiche “off-label” 113
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. 109
Dermatofibrosarcoma protuberans: studio retrospettivo sui pazienti trattati negli ultimi 10 anni 102
Manifestazioni cutanee correlate al trattamento con imatinib mesilato in pazienti affetti da dermatofibrosarcoma protuberans 97
Treatment of metastatic melanoma: a multidisciplinary approach 92
BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response 88
Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant. 85
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 83
Evaluation of PMNs functional and phenotypical alterations in mycosis fungoides patients. 83
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 80
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 79
Activity Of Imatinib Mesilate In Metastatic Melanoma 79
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 77
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study 76
Characterization and management of cutaneous side effects related to the immunosuppressive treatment in solid organ recipients 75
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNFα promoter gene polymorphism -308 G/A in patients with psoriasis. 75
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 74
Immunotherapy in transplanted patients: A special population that can no longer be ignored 74
Cutaneous melanoma metastases arising on a split-skin graft donor site 73
Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso 72
Progressione di malattia nei pazienti affetti da melanoma con linfonodo sentinella negativo 71
After Surgery: Follow-Up Guidelines of Melanoma Patients 71
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma cases 69
Cutaneous Adverse Events Related To Treatment With Imatinib 69
Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma 68
Gauze-based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum? 68
Th1, Th2, Th17 and Treg expression in cutaneous T-cell lymphoma patients: modulation of master gene targets. 67
TCRgamma-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples 66
Therapeutic approaches in advanced mycosis fungoides and Sezary Sindrome. A 30-year single institution experience 65
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 63
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice 58
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 58
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 58
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 57
Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors 57
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 57
Skin metastases of malignant melanoma: a clinical and prognostic survey 56
From the Aosta valley to the Sicily it is Always melanoma but... Results of a multicentric Italian study from the GIPMe 55
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 55
Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon? 53
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 52
Patologie cutanee in pazienti affetti da neoplasie ematologiche: studio osservazionale in 101 pazienti 51
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. 51
NEW PERSPECTIVES IN THE PHARMACOLOGICAL TREATMENT OF NON-MELANOMA SKIN CANCER 51
Infections in Sézary syndrome: A retrospective cohort study of 113 patients 51
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 51
A traveller's wart: tungiasis 50
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients 50
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 50
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma 49
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 49
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption. 47
Phenotype instability in Sézary cells: follow-up results in 107 patients 47
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: overview of the literature and clinical experience with long-term follow-up data 47
Terapia adiuvante con interferone alte dosi modificato e sviluppo di vitiligine: descrizione di un caso 45
HERV-E expression in peripheral mononuclear cells of patient with Psoriasis. 45
Epidemiology, Prevention and Clinical Diagnosis of Melanoma 44
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient 44
Dermatological approach to vemurafenib skin toxicity: a single centre experience 43
Mycosis Fungoides: disease evolution of the “lion queen” revisited. 42
Sezary syndrome: A single center retrospective study with proposal for a clinical score system 42
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management 42
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association 42
Localizzazioni cutanee di patologia onco-ematologiche: presentazione di quadri clinici particolari 40
Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses. 40
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 40
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 39
Treatment of Advanced Metastatic Melanoma 38
Extracorporeal photopheresis in the treatment of erythrodermic cutaneous T-cell lymphoma: combination therapy results and long-term follow-up. 36
Un'insolita acropustolosi 35
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) 35
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study 34
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 34
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. 33
Cutaneous metastases from malignant melanoma: clinical features and new therapeutic perspectives 31
Identification of risk factors for multiple non-melanoma skin cancers in italian kidney transplant recipients 29
Lack of detection of cutavirus DNA using PCR real time in Cutaneous T-cell Lymphomas (CTCL). 27
Perspectives of immunotherapy in non-melanoma skin cancers 25
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience 25
Real-life use of phototherapy in early-stage mycosis fungoides from the Cutaneous Lymphoma Commission of the Italian Lymphoma Foundation: Results of a web-based survey 25
Totale 9.551
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.202
article - articoli 0
book - libri 0
conference - conferenze 4.100
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020847 0 0 0 0 82 131 133 108 115 109 84 85
2020/2021686 76 43 49 41 63 74 48 33 56 59 53 91
2021/20221.145 60 44 48 62 129 55 53 55 35 68 253 283
2022/20232.040 225 194 61 173 170 421 125 200 257 47 120 47
2023/2024948 109 163 78 69 69 139 30 37 6 88 48 112
2024/2025710 42 132 74 200 262 0 0 0 0 0 0 0
Totale 9.773